319 related articles for article (PubMed ID: 12974390)
1. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.
Wu Y; Chen Z; Ullrich A
Biol Chem; 2003 Aug; 384(8):1215-26. PubMed ID: 12974390
[TBL] [Abstract][Full Text] [Related]
2. FGF-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the FGF pathway.
Zhou W; Feng X; Wu Y; Benge J; Zhang Z; Chen Z
Cell Res; 2009 Oct; 19(10):1165-77. PubMed ID: 19652666
[TBL] [Abstract][Full Text] [Related]
3. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
4. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
Hanafusa H; Torii S; Yasunaga T; Nishida E
Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
Wang X; Weng LP; Yu Q
Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
[TBL] [Abstract][Full Text] [Related]
6. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
7. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
8. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
9. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
10. Albumin activates ERK via EGF receptor in human renal epithelial cells.
Reich H; Tritchler D; Herzenberg AM; Kassiri Z; Zhou X; Gao W; Scholey JW
J Am Soc Nephrol; 2005 May; 16(5):1266-78. PubMed ID: 15829704
[TBL] [Abstract][Full Text] [Related]
11. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.
Ong SH; Hadari YR; Gotoh N; Guy GR; Schlessinger J; Lax I
Proc Natl Acad Sci U S A; 2001 May; 98(11):6074-9. PubMed ID: 11353842
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
14. FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity.
Li X; Brunton VG; Burgar HR; Wheldon LM; Heath JK
J Cell Sci; 2004 Dec; 117(Pt 25):6007-17. PubMed ID: 15564375
[TBL] [Abstract][Full Text] [Related]
15. Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins.
Gotoh N
Cancer Sci; 2008 Jul; 99(7):1319-25. PubMed ID: 18452557
[TBL] [Abstract][Full Text] [Related]
16. SNT-2 interacts with ERK2 and negatively regulates ERK2 signaling in response to EGF stimulation.
Huang L; Gotoh N; Zhang S; Shibuya M; Yamamoto T; Tsuchida N
Biochem Biophys Res Commun; 2004 Nov; 324(3):1011-7. PubMed ID: 15485655
[TBL] [Abstract][Full Text] [Related]
17. Conserved cross-interactions in Drosophila and Xenopus between Ras/MAPK signaling and the dual-specificity phosphatase MKP3.
Gómez AR; López-Varea A; Molnar C; de la Calle-Mustienes E; Ruiz-Gómez M; Gómez-Skarmeta JL; de Celis JF
Dev Dyn; 2005 Mar; 232(3):695-708. PubMed ID: 15704110
[TBL] [Abstract][Full Text] [Related]
18. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
[TBL] [Abstract][Full Text] [Related]
19. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
[TBL] [Abstract][Full Text] [Related]
20. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
